Literature DB >> 2523717

Serial determinations of HIV-1 titers in HIV-infected homosexual men: association of rising titers with CD4 T cell depletion and progression to AIDS.

J K Nicholson1, T J Spira, C H Aloisio, B M Jones, M S Kennedy, R C Holman, J S McDougal.   

Abstract

Lymphocyte subset enumerations, antibody titers to specific proteins of human immunodeficiency virus (HIV), and measurement of infectious HIV titers in peripheral blood mononuclear cells were performed on serial blood specimens from 15 HIV-infected homosexual men with chronic lymphadenopathy syndrome (LAS); 6 of these men have subsequently progressed to AIDS (progressors), and 9 have remained clinically stable (nonprogressors). For the earliest samples studied, no test distinguished those who would progress to AIDS from those who have not. The two groups diverged significantly about 1 year before AIDS diagnosis in the progressor group. Virus titers rose in progressors but remained relatively stable in nonprogressors. CD4 T cells and the CD4 T cell subset, 4B4, declined more rapidly in progressors than in nonprogressors. HIV antibody titers tended to decline in progressors, but the differences were significant only for antibody and to the pol-encoded proteins, p51/65, and the gag-encoded polyprotein, p55. Before the onset of clinical AIDS, progressors are distinguished from nonprogressors by markedly different rates of CD4 cell depletion and virus replication, but the elements that control these dynamics remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523717     DOI: 10.1089/aid.1989.5.205

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1.

Authors:  A J Whetsell; J B Drew; G Milman; R Hoff; E A Dragon; K Adler; J Hui; P Otto; P Gupta; H Farzadegan
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Radical prostatectomy in patients infected with human immunodeficiency virus.

Authors:  William C Huang; Eric O Kwon; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2006-08       Impact factor: 5.588

3.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody.

Authors:  J S McDougal; M S Kennedy; S L Orloff; J K Nicholson; T J Spira
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.

Authors:  D Mathez; D Paul; C de Bélilovsky; Y Sultan; J Deleuze; I Gorin; W Saurin; R Decker; J Leibowitch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.

Authors:  F K Yoshimura; K Diem; G H Learn; S Riddell; L Corey
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Prospective multicenter study on isolation of human immunodeficiency virus type 1 from homosexual men after seroconversion.

Authors:  P Gupta; H Farzadegan; D Imagawa; M Lee; L Kingsley; S Zhou; J Armstrong; C Rinaldo
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Relationship between frequency of infectious human immunodeficiency virus type 1-harboring cells and kinetics of viral replication: a simple procedure for quantitation of infectious virus-carrying cells in blood samples.

Authors:  W Lu; G Manolikakis; J M Andrieu
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.